Stephens & Co. Reiterates Overweight on Arvinas, Maintains $18 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 67.1%

Neg 0% Neu 67.1% Pos 0%

Stephens & Co. analyst Sudan Loganathan reiterates Arvinas (NASDAQ:ARVN) with a Overweight and maintains $18 price target.